| Title : Tetrahydroaminoacridine in HIV infections. The THA Study Group - Fredj_1989_Int.J.Clin.Pharmacol.Ther.Toxicol_27_408 |
| Author(s) : Fredj G , Dietlin F , Fredj D , Schwarzenberg L , Jasmin C , Meyer P , Misset JL |
| Ref : Int J Clinical Pharmacology & Therapeutics Toxicol , 27 :408 , 1989 |
|
Abstract :
On the basis of a similarity between certain neurological symptoms of AIDS and Alzheimer's disease, the authors studied the effects of tetrahydroaminoacridine (THA) in 9 patients with HIV infection. After 2 months of treatment, the preliminary results showed a significant increase in CD4 lymphocyte count as well as a decrease in p24 antigen level in 8 patients, of whom 4 became negative for the p24 antigen. |
| PubMedSearch : Fredj_1989_Int.J.Clin.Pharmacol.Ther.Toxicol_27_408 |
| PubMedID: 2793276 |
Fredj G, Dietlin F, Fredj D, Schwarzenberg L, Jasmin C, Meyer P, Misset JL (1989)
Tetrahydroaminoacridine in HIV infections. The THA Study Group
Int J Clinical Pharmacology & Therapeutics Toxicol
27 :408
Fredj G, Dietlin F, Fredj D, Schwarzenberg L, Jasmin C, Meyer P, Misset JL (1989)
Int J Clinical Pharmacology & Therapeutics Toxicol
27 :408